Category: Medical Equipment

  • Polyether Ether Ketone (PEEK) Interbody Devices Market Size In 2026: Regional Growth, Key Segments And Future Outlook

    Polyether Ether Ketone (PEEK) Interbody Devices Market Size In 2026: Regional Growth, Key Segments And Future Outlook

    Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

    Polyether Ether Ketone (PEEK) Interbody Devices Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?

    The polyether ether ketone (peek) interbody devices market has experienced robust growth in its size over recent years. It is projected to expand from $1.92 billion in 2025 to $2.07 billion in 2026, reflecting a compound annual growth rate (CAGR) of 7.8%. The historical growth can be ascribed to factors such as the increasing prevalence of degenerative disc disease, a rise in spinal trauma cases, the adoption of conventional spinal implants, an expanding geriatric population, and limited awareness about advanced interbody devices.

    The polyether ether ketone (peek) interbody devices market size is poised for substantial growth in the upcoming years. It is projected to expand to $2.74 billion in 2030, achieving a compound annual growth rate (CAGR) of 7.3%. This anticipated growth during the forecast period can be attributed to enhancements in PEEK material and design, an increase in minimally invasive surgeries, the development of hospital infrastructure, a heightened demand for personalized implants, and the global expansion of spinal fusion procedures. Significant trends identified for the forecast period encompass minimally invasive surgical techniques, improved biocompatibility and material innovation, the creation of radiolucent implants, the customization of spinal implants, and the rising prevalence of spinal fusion surgeries.

    Get A Free Sample Report With In-Depth Market Insights:

    https://thebusinessresearchcompany.com/sample_request?id=64816050&type=smp&name=Polyether%20Ether%20Ketone%20%28PEEK%29%20Interbody%20Devices%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Polyether Ether Ketone (PEEK) Interbody Devices Market Growth Drivers: What’s Behind The Acceleration?

    The increasing occurrence of spinal conditions is anticipated to drive the expansion of the PEEK interbody devices market moving forward. Spinal disorders encompass medical issues affecting the spine, including its bones, discs, nerves, and muscles. These disorders are becoming more common due to sedentary lifestyles, as extended periods of sitting and reduced physical activity weaken muscles supporting the spine and increase stress on it. PEEK interbody devices assist in treating spinal disorders by providing strong yet flexible support between vertebrae, thereby promoting spinal stability and encouraging natural bone growth, all while maintaining clear imaging for subsequent scans. For instance, in May 2023, according to Spinal Cord Inc., a US-based resource for individuals affected by spinal cord injuries and their families, the United States recorded approximately 18,000 new cases of spinal cord injuries (SCI) in 2023, with an estimated 302,000 people living with SCI across the country. Therefore, the rising prevalence of spinal disorders is a key factor boosting the PEEK interbody devices market’s growth.

    Polyether Ether Ketone (PEEK) Interbody Devices Market Segmentation: How Does The Market Break Down By Category?

    The polyether ether ketone (peek) interbody devices market covered in this report is segmented –

    1) By Product Type: Posterolateral Fusion Devices, Interbody Fusion Devices, Anterior Lumbar Interbody Fusion Devices (Alif), Extreme Lateral Interbody Fusion Devices (Xlif), Posterior Lumbar Interbody Fusion Devices (Plif), Transforaminal Lumbar Interbody Fusion Devices (Tlif)

    2) By Application: Spinal Fusion Surgery, Degenerative Disc Disease, Spinal Trauma, Spinal Deformity

    3) By Distribution Channel: Direct Sales, Third-Party Distributors

    4) By End-User: Hospitals And Clinics, Ambulatory Surgery Clinics, Specialty Spine Centers

    Subsegments:

    1) By Posterolateral Fusion Devices: Single-Level Devices, Multi-Level Devices, Expandable Devices

    2) By Interbody Fusion Devices: Cervical Fusion Devices, Lumbar Fusion Devices, Hybrid Devices

    3) By Anterior Lumbar Interbody Fusion Devices (ALIF): Flat-Profile Devices, Curved-Profile Devices, Cage-Style Devices

    4) By Extreme Lateral Interbody Fusion Devices (XLIF): Plated Devices, Cage-Style Devices, Oblique Devices

    5) By Posterior Lumbar Interbody Fusion Devices (PLIF): Lordotic Devices, Flat-Cage Devices, Mesh Or Porous Devices

    6) By Transforaminal Lumbar Interbody Fusion Devices (TLIF): Hollow Devices, Expandable Cages, Radiolucent Devices

    Polyether Ether Ketone (PEEK) Interbody Devices Market Trends: What’s Defining The Industry’s Next Phase?

    Leading firms within the polyether ether ketone (PEEK) interbody devices market are concentrating on creating novel solutions, including porous PEEK interbody spacers, with the aim of enhancing osseointegration and fostering superior spinal fusion results. These porous PEEK interbody spacers represent spinal implants constructed from polyether ether ketone, featuring a bone-like porous architecture that facilitates bone ingrowth, thereby contributing to improved osseointegration and increased spinal fusion stability. An example of this innovation occurred in March 2025 when Globus Medical Inc., a musculoskeletal technology company based in the US, introduced the COHERE ALIF Spacer. The company characterized this product as the inaugural Porous PEEK interbody spacer specifically engineered for anterior lumbar interbody fusion (ALIF) surgery. Comprising Globus Medical’s Porous PEEK advanced materials architecture, the COHERE ALIF Spacer is designed to stimulate bone ingrowth while preserving PEEK’s benefits in imaging and mechanical properties. This spacer is designated for ALIF procedures, forms part of an expanded anterior spine product lineup, and incorporates a porous surface/structure intended to boost biological fixation more effectively than smooth PEEK implants.

    Polyether Ether Ketone (PEEK) Interbody Devices Market Competitive Overview And Top Companies

    Major companies operating in the polyether ether ketone (peek) interbody devices market are Medtronic Inc., Stryker Corporation, Zimmer Biomet Holdings Inc., Globus Medical Inc., NuVasive Inc., Orthofix Medical Inc., Xtant Medical Holdings Inc., Alphatec Spine Inc., Spinal Elements Inc., Providence Medical Technology Inc., FossiLabs LLC, Life Spine Inc., Curiteva Inc., Medacta International S.A., LDR Holding Corporation, Cavendish Implants Limited, DePuy Synthes Spine, SeaSpine Holdings Corporation, Aesculap Spine, CoreLink LLC, Aurora Spine Corporation, ChoiceSpine LLC, K2M Group Holdings Inc.

    View The Full Polyether Ether Ketone (PEEK) Interbody Devices Market Report:

    https://thebusinessresearchcompany.com/report/polyether-ether-ketone-peek-interbody-devices-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Polyether Ether Ketone (PEEK) Interbody Devices Market Leading Geography: Which Region Contributes The Most Revenue?

    North America was the largest region in the polyether ether ketone (PEEK) interbody devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polyether ether ketone (peek) interbody devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Reach Out To Our Team:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Point-Of-Care-Testing (POCT) Market Growth Forecast Through 2030: Market Size And Trends In 2026

    Point-Of-Care-Testing (POCT) Market Growth Forecast Through 2030: Market Size And Trends In 2026

    Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

    Point-Of-Care-Testing (POCT) Market Size Forecast: How Big Could The Market Get By 2030?

    The point-of-care-testing (poct) market size has experienced significant growth in recent years. It is projected to expand from $50.79 billion in 2025 to $56.68 billion in 2026, at a compound annual growth rate (CAGR) of 11.6%. The market’s historical growth can be attributed to the rising prevalence of chronic diseases, an increasing necessity for rapid clinical decision-making, the expansion of emergency and critical care services, limited access to centralized laboratories, and the demand for immediate diagnostic results.

    The point-of-care-testing (POCT) market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $86.91 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.3%. This growth during the projection period is driven by factors such as progress in POCT device miniaturization, the expansion of home care and remote patient monitoring, an increase in infectious disease outbreaks, greater healthcare decentralization, and the rising uptake of self-testing diagnostics. Key trends expected during the forecast period encompass the increasing integration of rapid diagnostic testing at the point of care, a growing need for home-based and self-testing options, the wider availability of over-the-counter diagnostic products, an intensified focus on early disease detection and screening, and enhancements in the accuracy and sensitivity of POCT devices.

    Get A Free Sample Report With In-Depth Market Insights:

    https://thebusinessresearchcompany.com/sample_request?id=83696966&type=smp&name=Point-Of-Care-Testing%20%28POCT%29%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Point-Of-Care-Testing (POCT) Market Growth Factors Behind Sustained Expansion

    The expanding use of telemedicine is anticipated to drive the point-of-care-testing (POCT) market’s growth in the future. Telemedicine is defined as the remote provision of medical care, leveraging digital communication methods like video calls, phone calls, or secure messaging. The uptake of telemedicine stems from an increasing need for convenient, prompt, and contact-free healthcare, especially hastened by the COVID-19 pandemic. Point-of-care testing (POCT) facilitates telemedicine by offering quick, dependable diagnostic outcomes that can be immediately transmitted to distant healthcare professionals. For example, in April 2025, the American Hospital Association, a US-based professional organization, reported that over 12.6% of Medicare beneficiaries used telehealth services in 2023. Projections indicate that the physician count will reach up to 86,000 by 2036. Telehealth is crucial in addressing the growing shortage of physicians. Consequently, the widespread use of telemedicine is propelling the expansion of the point-of-care-testing (POCT) market.

    Point-Of-Care-Testing (POCT) Market Segment Trends And Revenue Contributors

    The point-of-care-testing (poct) market covered in this report is segmented –

    1) By Type: Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy And Fertility Testing, Blood Gas Or Electrolytes Testing, Urinalysis Testing, Other Types

    2) By Mode Of Purchase: Over-The-Counter Products, Prescribed Based Products

    3) By Technology: Immunoassays, Molecular Diagnostics, Microbial Detection, Polymerase Chain Reaction (PCR) Testing, Biochemical Testing

    4) By End-User: Clinical Laboratories, Ambulatory Care Facilities And Physician Offices, Pharmacies, Retail Clinics And E-Comm Platforms, Hospitals, Critical Care Centres, Urgent Care Centres, Home Care And Self-Testing, Other End-Users

    Subsegments:

    1) By Blood Glucose Testing: Self-Monitoring Blood Glucose Devices, Continuous Glucose Monitoring Devices, Flash Glucose Monitoring Devices

    2) By Infectious Diseases Testing: Human Immunodeficiency Virus (HIV) Testing, Hepatitis Testing, Influenza Testing, COVID-19 Testing, Other Infectious Diseases Testing

    3) By Cardiac Markers Testing: Troponin Testing, Creatine Kinase-MB (CK-MB) Testing, Myoglobin Testing, B-type Natriuretic Peptide (BNP) Testing

    4) By Coagulation Testing: Prothrombin Time (PT) Testing, Activated Partial Thromboplastin Time (aPTT) Testing, International Normalized Ratio (INR) Testing

    5) By Pregnancy And Fertility Testing: Pregnancy Test Kits, Ovulation Test Kits, Fertility Hormone Testing

    6) By Blood Gas Or Electrolytes Testing: Arterial Blood Gas Testing, Venous Blood Gas Testing, Electrolyte Testing

    7) By Urinalysis Testing: Urine Chemistry Analysis, Microscopic Urine Analysis, Urine Culture Testing

    8) By Other Types: Drug Abuse Testing, Allergy Testing, Cholesterol Testing, Thyroid Function Testing

    Point-Of-Care-Testing (POCT) Market Industry Trends Fueling Future Revenue Growth

    Leading companies in the point-of-care testing (POCT) market are increasingly directing their efforts towards technological innovations, including microfluidic rapid antimicrobial-susceptibility testing (AST) systems. This focus aims to address the rising demand for quicker, clinic-level diagnostics and enhanced antimicrobial stewardship in primary care. This microfluidic AST technology utilizes fluid channels at the micrometer scale to cultivate and identify bacteria from patient samples, such as urine, and determine their antibiotic susceptibility in a significantly reduced timeframe compared to conventional culture-based methods, which often take several days. For instance, in June 2023, Sysmex Corporation, a Japan-based diagnostics company, unveiled the PA 100 AST System. This compact POCT analyser incorporates Sysmex Astrego’s proprietary microfluidic cartridges to identify bacteria in approximately 15 minutes and deliver comprehensive AST results in about 30 minutes. The system is highly intuitive: healthcare professionals simply place the sample into a single-use cartridge, insert it into the desktop analyser, and receive automated AST readouts without needing specialized laboratory training. This swift turnaround enables timely antibiotic decisions during the first patient visit, thereby supporting initiatives to lessen inappropriate prescriptions and combat antimicrobial resistance (AMR).

    Point-Of-Care-Testing (POCT) Market Competitive Landscape: Which Companies Lead The Industry?

    Major companies operating in the point-of-care-testing (poct) market are Johnson & Johnson, F. Hoffmann‑La Roche Ltd., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, BioMérieux SA, QuidelOrtho Corporation, Sysmex Corporation, Nova Biomedical Corporation, LifeScan Inc., Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Trinity Biotech Plc, Sinocare Inc., Menarini Diagnostics, Princeton BioMeditech, Helena Laboratories, Chembio Diagnostics, ARKRAY, Accriva, ACON Laboratories, Sekisui Diagnostics, PTS Diagnostics, Meridian Bioscience

    View The Full Point-Of-Care-Testing (POCT) Market Report:

    https://thebusinessresearchcompany.com/report/point-of-care-testing-poct-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Point-Of-Care-Testing (POCT) Market Regional Outlook: Where Is Opportunity Concentrated?

    North America was the largest region in the point-of-care testing (POCT) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point-of-care-testing (poct) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Reach Out To Our Team:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Point-of-Care Technology Market Analysis: $47.41 Billion Market Size In 2026 And Future Growth Prospects

    Point-of-Care Technology Market Analysis: $47.41 Billion Market Size In 2026 And Future Growth Prospects

    Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

    Point-of-Care Technology Market Revenue Outlook: What CAGR Lies Ahead Through 2030?

    The point-of-care technology market size has demonstrated robust growth over recent years. Projections indicate it will expand from $43.21 billion in 2025 to $47.41 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.7%. This historical expansion is attributable to factors such as reliance on centralized laboratory testing, restricted availability of rapid diagnostics in isolated regions, the increasing prevalence of infectious diseases, a rise in hospital patient numbers, and the early uptake of fundamental point-of-care instruments.

    The point-of-care technology market is projected to experience substantial expansion in the coming years, with its size forecast to reach $67.94 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.4%. This anticipated growth can be ascribed to advancements in microfluidics and PCR technologies, an increasing prevalence of chronic and lifestyle diseases, the expansion of homecare and decentralized healthcare models, greater healthcare digitization, and supportive regulatory frameworks for rapid diagnostics. Prominent trends expected during this forecast period include an escalating demand for rapid diagnostic testing at the point of care, a rise in the adoption of home-based and remote testing solutions, the development of portable and handheld diagnostic devices, an broadening of infectious and chronic disease testing, and an enhanced focus on user-friendliness and quicker turnaround times for results.

    Get A Free Sample Report With In-Depth Market Insights:

    https://thebusinessresearchcompany.com/sample_request?id=77621095&type=smp&name=Point-of-Care%20Technology%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Point-of-Care Technology Market Demand Drivers Opening New Revenue Streams

    The increasing prevalence of chronic illnesses is anticipated to propel the growth of the point-of-care technology market. Chronic illnesses are enduring health conditions that persist for extended periods, typically requiring ongoing care and adjustments to daily life. These conditions are on the rise due to inactive lifestyles, as prolonged sitting and insufficient physical activity elevate the risk of diseases such as heart conditions and diabetes. Point-of-care technology assists in managing chronic illnesses by offering quick, on-site diagnostic testing, proving ideal for clinics, homes, and remote care environments. It minimizes delays in treatment by delivering real-time results, thereby enhancing patient monitoring and overall healthcare convenience. For instance, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, marking an 18% increase from 3,065,825 cases in 2022. Therefore, the growing occurrence of chronic illnesses is a significant factor driving the point-of-care technology market.

    Point-of-Care Technology Market Segment Analysis Spotlighting Growth Areas

    The point-of-care technology market covered in this report is segmented –

    1) By Product Type: Diagnostics Devices, Monitoring Devices, Therapeutic Devices, Data Management Systems

    2) By Ownership Model: Standalone Solutions, Integrated Solutions, Cloud-Based Solutions

    3) By Technology: Microfluidics, Polymerase Chain Reaction (PCR), Immunoassays

    4) By Application: Infectious Disease Testing, Glucose Monitoring, Cardiometabolic Monitoring, Pregnancy And Fertility Testing, Other Applications

    5) By End-User: Hospitals, Clinics, Homecare Settings, Ambulatory Surgical Centers

    Subsegments:

    1) By Diagnostics Devices: Blood Glucose Monitoring Devices, Infectious Disease Testing Devices, Cardiac Marker Testing Devices, Coagulation Testing Devices, Pregnancy And Fertility Testing Devices, Urinalysis Testing Devices, Hematology Testing Devices, Cholesterol Testing Devices

    2) By Monitoring Devices: Vital Signs Monitoring Devices, Continuous Glucose Monitoring Devices, Cardiac Monitoring Devices, Respiratory Monitoring Devices

    3) By Therapeutic Devices: Insulin Delivery Devices, Nebulizers, Dialysis Machines, Infusion Pumps

    4) By Data Management Systems: Point Of Care (POC) Data Integration Systems, Point Of Care (POC) Middleware Solutions, Point Of Care (POC) Data Analytics Platforms

    Point-of-Care Technology Market Trends Powering Strategic Industry Growth

    Leading companies in the point-of-care technology market are concentrating on creating technologically advanced solutions, particularly AI-powered diagnostic platforms, to boost accuracy, speed, and accessibility in detecting diseases. AI-powered diagnostic platforms are sophisticated systems that harness artificial intelligence to quickly analyze medical data, enabling real-time, on-site testing for severe conditions like cancer. For instance, in February 2025, Avitia Inc., a Canada-based point-of-care diagnostics company, introduced an AI-powered platform tailored for rapid, point-of-care cancer testing. This platform merges machine learning algorithms with portable diagnostic devices, allowing healthcare providers to perform fast, precise cancer screening outside traditional lab environments. Such innovation reduces turnaround times, improves early detection, and minimizes the need for complex infrastructure, thereby making advanced diagnostics more reachable in remote or underserved areas.

    Point-of-Care Technology Market Competitive Landscape: Who Leads The Industry?

    Major companies operating in the point-of-care technology market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Hologic Inc., bioMérieux SA, Quidel Corporation, Sysmex Corporation, Cepheid Inc., Radiometer Medical ApS, Nova Biomedical, Sekisui Diagnostics LLC, Abaxis Inc., BHR Biosynex, EKF Diagnostics Holdings plc, Acon Laboratories Inc., Trinity Biotech plc, Chembio Diagnostics Inc., Arkray Inc., Orchard Software Corporation, Point of Care Biomedical Private Limited

    View The Full Point-of-Care Technology Market Report:

    https://thebusinessresearchcompany.com/report/point-of-care-technology-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Point-of-Care Technology Market Geographic Landscape: Which Region Leads Industry Growth?

    North America was the largest region in the point-of-care technology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point-of-care technology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Reach Out To Our Team:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Point-Of-Care Molecular Diagnostics Market 2026 Market Size And Growth Forecast: Key Trends To Watch

    Point-Of-Care Molecular Diagnostics Market 2026 Market Size And Growth Forecast: Key Trends To Watch

    Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

    Point-Of-Care Molecular Diagnostics Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?

    The point-of-care molecular diagnostics market size has experienced swift expansion over the last few years. It is projected to increase from $3.98 billion in 2025 to $4.58 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 15.0%. The growth observed in previous periods stems from factors such as the rising occurrence of infectious diseases, the broadening scope of emergency diagnostic testing, an elevated need for swift clinical decision support, advancements in molecular assay technologies, and the expanding implementation of POC diagnostics in hospital environments.

    The point-of-care molecular diagnostics market is anticipated to expand rapidly in the near future. By 2030, this market is set to reach a valuation of $7.91 billion, demonstrating a compound annual growth rate (CAGR) of 14.7%. Key drivers for this growth during the projected timeframe include the rising popularity of home-based molecular testing, greater investments in infrastructure for rapid diagnostics, broader applications for respiratory and oncology testing, increased incorporation of cloud-based diagnostic platforms, and a heightened emphasis on detecting diseases at early stages. Significant trends anticipated in the forecast period encompass a wider uptake of rapid molecular testing platforms, a growing need for decentralized diagnostic options, more widespread integration of automated sample processing, an enlargement of syndromic testing panels, and an intensified focus on achieving quick turnaround times.

    Get A Free Sample Report With In-Depth Market Insights:

    https://thebusinessresearchcompany.com/sample_request?id=74699384&type=smp&name=Point-Of-Care%20Molecular%20Diagnostics%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Point-Of-Care Molecular Diagnostics Market Growth Backed By Core Demand Fundamentals

    The quick rise in the incidence of infectious and respiratory ailments is anticipated to substantially fuel the expansion of the point-of-care molecular diagnostics market. Respiratory infections, which include viruses or bacteria, originate from microorganisms affecting the respiratory system. These tiny organisms can spread via coughing, sneezing, or physical contact. Treating severe respiratory conditions involves various methods like inhalers, oral medicines, intravenous therapies, and point-of-care molecular diagnostic tools for patient recovery. For example, data from June 2024, released by the UK Health Security Agency, a UK-based government body, indicated that from week 40 of 2022 to week 15 of 2023, 108 NHS trusts in England recorded 1,681 critical care admissions due to confirmed influenza. This contrasts with the prior season, where 182 admissions were noted across 114 trusts, rising to 316 by week 39 of 2022. Consequently, the swift emergence of infectious and respiratory diseases, along with associated fatalities, will propel the point-of-care molecular diagnostics market forward.

    Point-Of-Care Molecular Diagnostics Market Segment Performance And Emerging Opportunities

    The point-of-care molecular diagnostics market covered in this report is segmented –

    1) By Product: Assays And Kits, Instruments And Analyzers

    2) By Application: Respiratory Infections, Gastrointestinal Infections, Sexually Transmitted Infections (STIs), Hospital-Acquired Infections (HAIs), Bloodstream and Sepsis-Related Infections

    3) By End-User: Decentralized Labs, Hospitals, Home Care, Assisted Living Healthcare Facilities

    Subsegments:

    1) By Assays And Kits: Nucleic Acid Amplification Tests (NAATs), Rapid Diagnostic Tests, Molecular Detection Kits, Reagents And Consumables

    2) By Instruments And Analyzers: Microfluidic Devices, Point-of-Care Analyzers

    Point-Of-Care Molecular Diagnostics Market Growth Trends Reshaping The Competitive Landscape

    Leading companies operating within the point-of-care molecular diagnostics market are concentrating on delivering technologically advanced solutions to strengthen their market standing. These businesses are adopting next-generation point-of-care molecular diagnostics technologies solutions and associated services, such as enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR), and mass spectrometry (MS), situ hybridizations, spectral karyotyping imaging, DNA microarrays, among others, for implementation on POC devices designed to accelerate analysis times and lower costs. For instance, in May 2023, Sensible Diagnostics, a US-based diagnostics company, introduced a 10-minute point-of-care PCR system. Sensible Diagnostics is drawing upon the experience Curative gained with its diagnostics business throughout the pandemic. The firm stated it has conducted over two million molecular point-of-care COVID-19 tests, and its PCR platform offers a 10-minute time-to-result.

    Point-Of-Care Molecular Diagnostics Market Company Landscape And Competitive Strategy

    Major companies operating in the point-of-care molecular diagnostics market are Abbott Laboratories, F Hoffmann La Roche Ltd, BioMérieux SA, Hologic Inc, Becton Dickinson and Company, Siemens Healthineers AG, QuidelOrtho Corporation, Bio Rad Laboratories Inc, Qiagen N V, Biocartis Group NV, DiaSorin S p A, SD Biosensor Inc, Cue Health Inc, Visby Medical Inc, Binx Health Inc, Molbio Diagnostics Pvt Ltd, Credo Diagnostics Biomedical Pvt Ltd, Genetron Health, Mammoth Biosciences Inc, Seegene Inc

    View The Full Point-Of-Care Molecular Diagnostics Market Report:

    https://thebusinessresearchcompany.com/report/point-of-care-molecular-diagnostics-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Point-Of-Care Molecular Diagnostics Market Largest Region: Which Geography Holds The Biggest Share?

    North America was the largest region in the point-of-care molecular diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point-of-care molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Reach Out To Our Team:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Point-of-Care Diagnostics Devices And Equipment Market Size Forecast: How The Industry Is Expected To Grow From 2026 To 2030

    Point-of-Care Diagnostics Devices And Equipment Market Size Forecast: How The Industry Is Expected To Grow From 2026 To 2030

    Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

    Point-of-Care Diagnostics Devices And Equipment Market Forecast: What Value Will The Market Reach By 2030?

    The point-of-care diagnostics devices and equipment market size has experienced significant expansion in recent years. It is anticipated to grow from $64.11 billion in 2025 to $71.62 billion in 2026, at a compound annual growth rate (CAGR) of 11.7%. This historical growth can be attributed to factors such as the increasing burden of chronic diseases, a greater demand for rapid clinical decision-making, the expansion of outpatient healthcare services, the rising adoption of portable diagnostic devices, and the growth of preventive healthcare practices.

    The point-of-care diagnostics devices and equipment market is projected to experience substantial expansion over the coming years. Its valuation is anticipated to reach $118.72 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 13.5%. This forecasted expansion stems from factors such as a heightened need for home healthcare diagnostics, the increasing embrace of digital health ecosystems, the broadening scope of infectious disease screening initiatives, the growing incorporation of AI-powered diagnostic assistance, and a stronger emphasis on remote patient monitoring. Key developments expected during this period involve a greater uptake of rapid diagnostic testing devices, a surging desire for decentralized healthcare diagnostics, the deeper integration of connected point-of-care systems, the proliferation of home-based testing options, and an elevated commitment to intuitive device interfaces.

    Get A Free Sample Report With In-Depth Market Insights:

    https://thebusinessresearchcompany.com/sample_request?id=87519147&type=smp&name=Point-of-Care%20Diagnostics%20Devices%20And%20Equipment%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Point-of-Care Diagnostics Devices And Equipment Market Growth Catalysts And Demand Drivers

    The expanding use of mobile health technologies is anticipated to fuel the expansion of the point-of-care diagnostics devices market in the future. Mobile health encompasses the application of portable devices like smartphones and tablets, alongside other wireless innovations such as wearable technology, to provide healthcare services, disseminate information, and oversee health data. Point-of-care diagnostics (POC) devices are vital within mobile health (mHealth) because they facilitate quick and accessible testing and data acquisition directly at or close to where the patient is located. Such devices are engineered to deliver instant outcomes for diverse medical examinations and frequently interface with mobile applications or link to smartphones for purposes of data handling and transfer. For example, PharmiWeb reported in February2025 that approximately 23% of healthcare interactions are projected to occur virtually in 2025. Consequently, the heightened embrace of mobile health technologies is actively stimulating the growth of the point-of-care diagnostics devices market.

    Point-of-Care Diagnostics Devices And Equipment Market Segment Landscape And Growth Outlook

    The point-of-care diagnostics devices and equipment market covered in this report is segmented –

    1) By Type: Infectious disease testing kits, Cardio metabolic monitoring kits, Cholesterol testing kits, Pregnancy and fertility tests kits, Tumor Or cancer markers, Urinalysis testing kits, Hematology testing kits, Drugs of abuse testing kits, Fecal occult testing kits, Other Types

    2) By Prescription Mode: Prescription-based Testing Devices, Over-The-Counter (OTC) Testing Devices

    3) By End User: Professional diagnostic centers, Hospitals/critical care centers, Outpatient healthcare Setting, Ambulatory care settings, Research laboratories, Home

    Subsegments:

    1) By Infectious Disease Testing Kits: HIV Testing Kits, Hepatitis Testing Kits, Malaria Testing Kits, Influenza Testing Kits, COVID-19 Testing Kits, Other Infectious Disease Testing Kits

    2) By Cardio Metabolic Monitoring Kits: Blood Glucose Testing Kits, Blood Pressure Monitoring Kits, Lipid Testing Kits, Other Cardio Metabolic Monitoring Kits

    3) By Cholesterol Testing Kits: Total Cholesterol Testing Kits, HDL Cholesterol Testing Kits, LDL Cholesterol Testing Kits, Triglyceride Testing Kits

    4) By Pregnancy and Fertility Test Kits: Pregnancy Test Kits, Ovulation Test Kits, Fertility Monitoring Kits

    5) By Tumor Or Cancer Markers: Prostate-Specific Antigen (PSA) Test Kits, Human Epidermal Growth Factor Receptor 2 (HER2) Test Kits, CA-125 Test Kits, Alpha-Fetoprotein (AFP) Test Kits, Other Cancer Marker Test Kits

    6) By Urinalysis Testing Kits: Protein Testing Kits, Glucose Testing Kits, pH Testing Kits, Specific Gravity Testing Kits, Nitrite Testing Kits, Other Urinalysis Testing Kits

    7) By Hematology Testing Kits: Complete Blood Count (CBC) Kits, Hemoglobin Testing Kits, Hematocrit Testing Kits, Platelet Count Kits, Other Hematology Testing Kits

    8) By Drugs of Abuse Testing Kits: Marijuana Testing Kits, Cocaine Testing Kits, Opioid Testing Kits, Amphetamine Testing Kits, Other Drugs of Abuse Testing Kits

    9) By Fecal Occult Testing Kits: Stool Blood Test Kits, Occult Blood Screening Kits, Other Fecal Occult Testing Kits

    10) By Other Types: Glucose Monitoring Kits, Temperature Monitoring Kits, Oxygen Saturation Monitoring Kits, Other Specialty Point-of-Care Kits

    Point-of-Care Diagnostics Devices And Equipment Market Trends Shaping Long-Term Demand

    Leading companies in the point-of-care diagnostic devices and equipment market are developing innovative products, such as Cippoint, to improve access to healthcare and reduce diagnostic times. Cippoint is a point-of-care testing device suitable for multiple health conditions. This advanced device offers a comprehensive range of testing parameters, including cardiac markers, diabetes, infectious diseases, fertility, thyroid function, inflammation, metabolic markers, and coagulation markers. For instance, in January 2023, Cipla Limited, an India-based pharmaceutical company, launched Cippoint as a point-of-care testing device for various health conditions, confirming its status as a state-of-the-art tool with wide-ranging testing capabilities. Cippoint operates as an immunofluorescence-based quantitative analyzer, enabling healthcare professionals to receive test results within 3 to 15 minutes, which facilitates more rapid and efficient clinical decisions. Furthermore, its ease of use makes it deployable in diverse settings like hospitals, clinics, and mobile vans.

    Point-of-Care Diagnostics Devices And Equipment Market Key Players Shaping Industry Direction

    Major companies operating in the point-of-care diagnostics devices and equipment market are Abbott Laboratories, F. Hoffmann-La Roche AG, Siemens Healthineers, Danaher, Beckman Coulter, Becton Dickinson and Company, Qiagen N.V., Johnson & Johnson, Alere, BioMerieux, Chembio Diagnostic Systems, Quidel Corporation, EKF Diagnostics, Trinity Biotech Plc, OraSure Technologies, Sysmex Corporation, Radiometer Medical ApS, Response Biomedical Corporation, Bio-Rad Laboratories, Illumina, Thermo Fisher Scientific Inc., LabCorp, Luminex Corporation, LifeScan, Nova, Sekisui Diagnostics, Hemocue AB, Akers Biosciences,

    View The Full Point-of-Care Diagnostics Devices And Equipment Market Report:

    https://thebusinessresearchcompany.com/report/point-of-care-diagnostics-devices-and-equipment-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Point-of-Care Diagnostics Devices And Equipment Market Regional Analysis: Which Geography Leads On Revenue?

    North America was the largest region in the point-of-care diagnostic devices and equipment market in 2025. Asia-Pacific was the second-largest region in the global point-of-care diagnostics devices and equipment market. The regions covered in the point-of-care diagnostics devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Reach Out To Our Team:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Point-of-Care (POC) Coagulation Testing Devices Market Reaches $3.49 Billion In 2026: Forecast And Growth Opportunities

    Point-of-Care (POC) Coagulation Testing Devices Market Reaches $3.49 Billion In 2026: Forecast And Growth Opportunities

    Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

    Point-of-Care (POC) Coagulation Testing Devices Market Size Outlook: How Quickly Will Revenue Expand Through 2030?

    The point-of-care (poc) coagulation testing devices market size has demonstrated significant growth in recent years. It is forecast to grow from $2.32 billion in 2025 to $2.55 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.7%. The historical expansion can be attributed to the rising prevalence of coagulation disorders, the increased use of anticoagulant therapies, the expansion of decentralized healthcare settings, the growing adoption of point-of-care diagnostics, and advancements in coagulation testing technologies.

    The point-of-care (poc) coagulation testing devices market size is projected for substantial expansion over the coming years. This market is anticipated to reach $3.49 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 8.2%. The expansion during the forecast period is largely due to factors such as a greater need for home healthcare diagnostics, an increased emphasis on personalized medicine, the growth of telehealth-enabled diagnostic solutions, an expanding elderly demographic, and ongoing advancements in microfluidic testing platforms. Key developments anticipated in this period encompass the wider adoption of portable coagulation monitors, a heightened call for quick diagnostic testing at the point of care, the growing prevalence of home-based coagulation testing kits, improved wireless data connectivity in poc devices, and a stronger emphasis on the precision and dependability of tests.

    Get A Free Sample Report With In-Depth Market Insights:

    https://thebusinessresearchcompany.com/sample_request?id=98888268&type=smp&name=Point-of-Care%20%28POC%29%20Coagulation%20Testing%20Devices%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Point-of-Care (POC) Coagulation Testing Devices Market Opportunity Drivers: What’s Unlocking New Revenue Potential?

    An increase in the occurrence of blood clotting disorders is anticipated to stimulate the expansion of the point-of-care (POC) coagulation testing devices market moving forward. These conditions hinder the blood’s capacity to clot correctly. Certain lifestyle habits, such as smoking, heavy alcohol consumption, and a sedentary existence, can contribute to blood clotting disorders. These activities can adversely affect the health of blood vessels, levels of clotting factors, and blood circulation, elevating the potential for irregular clot formation. POC coagulation testing devices allow medical providers to rapidly evaluate a patient’s coagulation status, facilitating prompt adjustments to medication dosages and treatment plans. For example, in July 2025, the National Blood Authority, an Australia-based blood management agency, reported that 2,788 patients were living with hereditary haemophilia A (HMA) in 2023–2024, an increase from 2,681 patients in 2022–2023. Thus, the growing prevalence of blood clotting disorders is a key driver for the growth of the point-of-care (POC) coagulation testing devices market.

    Point-of-Care (POC) Coagulation Testing Devices Market Breakdown By Product Type And Application

    The point-of-care (poc) coagulation testing devices market covered in this report is segmented –

    1) By Product Type: Coagulation Monitors, Consumables, Coagulation Analyzers

    2) By Technology: Optical Technology, Mechanical Technology, Electrochemical Technology

    3) By Method: Prothrombin Time And International Normalized Ratio, Viscoelastic Coagulation Monitoring, Other Methods

    4) By Application: Coagulation Testing, Other Applications

    5) By End-User: Hospitals, Diagnostic Laboratories, Clinics, Other End-Users

    Subsegments:

    1) By Coagulation Monitors: Prothrombin Time (Pt) Monitors, International Normalized Ratio (Inr) Monitors, Activated Partial Thromboplastin Time (Aptt) Monitors, Whole Blood Coagulation Monitors, Clotting Time Monitors

    2) By Consumables: Test Strips, Reagents, Control Solutions, Calibration Kits, Lancets And Needles

    3) By Coagulation Analyzers: Portable Coagulation Analyzers, Benchtop Coagulation Analyzers, Fully Automated Coagulation Analyzers, Semi-Automated Coagulation Analyzers, Coagulation Testing Kits (For Home Use)

    Point-of-Care (POC) Coagulation Testing Devices Market Innovation Trends Shaping Future Development

    Key companies operating within the point-of-care (POC) coagulation testing devices market are engaged in the development of immunofluorescence-based quantitative analyzers to enhance the identification and management of coagulation disorders. These analyzers function as diagnostic instruments in laboratory environments, designed to accurately measure and quantify specific proteins or molecules involved in the coagulation process, thereby assisting in the diagnosis and treatment of blood clotting conditions. For instance, in January 2023, Cipla Limited, an India-based pharmaceutical firm, introduced Cippoint. This immunofluorescence-based quantitative analyzer employs immunofluorescence technology to yield quick and precise test results within 3 to 15 minutes, thus expediting clinical decision-making processes. With its user-friendly interface, swift processing time, and comprehensive testing features, Cippoint is instrumental in boosting diagnostic efficiency, enabling timely medical judgments, and improving patient care outcomes.

    Point-of-Care (POC) Coagulation Testing Devices Market Competitive Analysis Of Leading Industry Participants

    Major companies operating in the point-of-care (poc) coagulation testing devices market are Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Bio-Rad Laboratories Inc., Werfen, Haemonetics Corporation, HemoSonics LLC, Sysmex Corporation, Nihon Kohden Corporation, HORIBA Medical, Helena Laboratories Corporation, Diagnostica Stago, Sekisui Diagnostics, Instrumentation Laboratory, Trinity Biotech plc, CoaguSense Inc., iLine Microsystems, Medirox AB, Hemochron Systems, Axis-Shield Diagnostics

    View The Full Point-of-Care (POC) Coagulation Testing Devices Market Report:

    https://thebusinessresearchcompany.com/report/point-of-care-poc-coagulation-testing-devices-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Point-of-Care (POC) Coagulation Testing Devices Market Geographic Spread And Regional Opportunities

    North America was the largest region in the point-of-care (POC) coagulation testing devices market in 2025. The regions covered in the point-of-care (poc) coagulation testing devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Reach Out To Our Team:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Point-of-Care (POC) Coagulation Testing Market Growth In 2026: Market Size, Key Drivers And Future Outlook

    Point-of-Care (POC) Coagulation Testing Market Growth In 2026: Market Size, Key Drivers And Future Outlook

    Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

    Point-of-Care (POC) Coagulation Testing Market Size, Value And Growth Trajectory Through 2030

    The point-of-care (poc) coagulation testing market size has shown consistent expansion in recent years. Its valuation is projected to increase from $1.25 billion in 2025 to $1.3 billion in 2026, achieving a compound annual growth rate (CAGR) of 4.2%. The development observed in previous periods can be linked to the increasing occurrence of cardiovascular diseases requiring anticoagulation treatment, a greater need for quick coagulation results in operating theatres and intensive care units, the early clinical acceptance of optical and mechanical poc testing systems, the broadening scope of coagulation monitoring within hospital and clinic environments, and enhanced understanding of point-of-care diagnostics for improving treatment efficacy.

    The point-of-care (poc) coagulation testing market is projected to experience consistent expansion over the upcoming years, reaching a valuation of $1.52 billion by 2030, driven by a compound annual growth rate (CAGR) of 4.1%. This anticipated growth during the forecast period is primarily fueled by a growing move towards decentralized and home-based coagulation monitoring, increased use of electrochemical detection technologies, higher volumes of procedures in emergency and trauma care settings, wider availability through retail and direct tender distribution channels, and an intensified focus on reducing processing times and enhancing therapeutic results. Key trends expected over the forecast period encompass the increasing integration of rapid bedside coagulation testing in critical and emergency care, the expanded application of poc coagulation devices for tracking anticoagulation therapy, a rising demand for portable and handheld coagulation analysis instruments, the broader deployment of coagulation testing in home care and outpatient scenarios, and a surging need for real-time clinical decision support facilitated by near-patient testing.

    Get A Free Sample Report With In-Depth Market Insights:

    https://thebusinessresearchcompany.com/sample_request?id=24488942&type=smp&name=Point-of-Care%20%28POC%29%20Coagulation%20Testing%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Point-of-Care (POC) Coagulation Testing Market Growth Momentum: What Factors Are Shaping Demand?

    The escalating occurrence of cardiovascular diseases is projected to stimulate the expansion of the point-of-care (POC) coagulation testing market going forward. Cardiovascular diseases (CVDs) encompass various conditions affecting the heart and blood vessels, such as coronary heart disease, cerebrovascular disease, and peripheral arterial disease. Point-of-care (POC) coagulation testing is valuable in managing Cardiovascular diseases (CVDs) due to its ability to provide real-time coagulation status updates. This enables prompt decisions on interventions and lowers the risk of bleeding complications post-cardiac surgery. As an illustration, in October 2024, the Centers for Disease Control and Prevention, a US-based public health institute, reported that in 2023, roughly 1 out of every 6 deaths from cardiovascular diseases affected adults younger than 65 years old, and 919,032 people died from cardiovascular disease, representing 1 in every 3 deaths. Thus, the increasing prevalence of cardiovascular diseases is propelling the growth of the point-of-care (POC) coagulation testing market.

    Point-of-Care (POC) Coagulation Testing Market Segment Analysis And Revenue Potential

    The point-of-care (poc) coagulation testing market covered in this report is segmented –

    1) By Technology: Optical Technology, Mechanical Technology, Electrochemical Technology

    2) By Distribution Channel: Direct Tenders, Retail

    3) By End-User: Hospitals, Clinics, Home care

    Subsegments:

    1) By Optical Technology: Reflectance Photometry, Fluorescence Detection, Colorimetric Detection

    2) By Mechanical Technology: Mechanical Oscillation, Ultrasonic Detection

    3) By Electrochemical Technology: Amperometric Detection, Potentiometric Detection, Conductometric Detection

    Point-of-Care (POC) Coagulation Testing Market Trends Redefining Industry Growth

    Leading companies in the point-of-care (POC) coagulation testing market are prioritizing the innovation of connected POC coagulation solutions through strategic partnerships to secure a competitive advantage. A strategic collaboration is defined as a formal arrangement between two or more parties that agree to work together to achieve specific, predetermined, and mutually beneficial goals. For example, in January 2023, Jana care, a US-based company that develops biomarker assays for its proprietary digital health platform, partnered with Roche Diagnostics, a Switzerland-based company known for developing diagnostic tests, instruments, and digital solutions that enhance healthcare. This collaboration seeks to develop and distribute a point-of-care blood testing platform designed for screening chronic kidney disease and heart failure. This cutting-edge platform will permit patients to conduct blood tests at home, with clinicians reviewing the results remotely.

    Point-of-Care (POC) Coagulation Testing Market Leading Companies And Competitive Benchmarking

    Major companies operating in the point-of-care (poc) coagulation testing market are Siemens Healthcare GmbH, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Danaher Corporation, Sysmex Corporation, IDEXX Laboratories Inc., Quidel Corporation, Werfen SA, Nihon Kohden Corporation, Horiba Ltd., Hycel, Nova Biomedical Corporation, Haemonetics Corporation, Maccura Biotechnology Co. Ltd., Helena Laboratories Corporation, Abaxis Inc., ARKRAY Inc., Radiometer Medical ApS, HemoSonics LLC, iLine Microsystems SL, Corgenix Medical Corporation, Quotient Limited, Micropoint Bioscience Inc., Beijing Succeeder Technology Inc., EKF Diagnostics Holdings plc

    View The Full Point-of-Care (POC) Coagulation Testing Market Report:

    https://thebusinessresearchcompany.com/report/point-of-care-poc-coagulation-testing-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Point-of-Care (POC) Coagulation Testing Market Top Region By Revenue And Market Share

    North America was the largest region in the point-of-care (POC) coagulation testing market in 2025. The regions covered in the point-of-care (poc) coagulation testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Reach Out To Our Team:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Point Of Care Lipid Test Market Size And Forecast 2026–2030: Trends Driving Industry Expansion

    Point Of Care Lipid Test Market Size And Forecast 2026–2030: Trends Driving Industry Expansion

    Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

    Point Of Care Lipid Test Market CAGR Outlook And Future Development

    The point of care lipid test market has demonstrated strong growth in recent years. This market is projected to expand from $0.74 billion in 2025 to $0.82 billion in 2026, at a compound annual growth rate (CAGR) of 9.7%. The growth observed in the past can be attributed to the increasing prevalence of cardiovascular diseases, the demand for rapid testing, progress in biosensor technology, increased awareness of cholesterol management, and the availability of point-of-care devices.

    The point of care lipid test market size is forecasted to undergo significant expansion in the coming years, with expectations to reach $1.17 billion by 2030, growing at a compound annual growth rate (CAGR) of 9.4%. This anticipated growth is primarily driven by the integration of mobile applications and cloud platforms, the expansion into home care settings, increased adoption within clinics and hospitals, the development of multi-analyte tests, and collaborative efforts between device and software providers. Prominent trends throughout the forecast period include the rise of fingerstick lipid testing, the availability of portable lipid analyzers, the use of multi-parameter analyzers, rapid cardiovascular risk assessment capabilities, and the prevalence of home-based lipid monitoring solutions.

    Get A Free Sample Report With In-Depth Market Insights:

    https://thebusinessresearchcompany.com/sample_request?id=94589313&type=smp&name=Point%20Of%20Care%20Lipid%20Test%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Point Of Care Lipid Test Market Expansion Drivers: What’s Shaping Future Growth?

    The rising incidence of cardiovascular conditions is projected to boost the expansion of the point of care lipid test market in the future. Cardiovascular diseases encompass various heart and blood vessel disorders, such as coronary artery disease, stroke, and high blood pressure, frequently caused by atherosclerosis connected to irregular cholesterol and triglyceride levels. The escalating occurrence of cardiovascular ailments stems from increasingly sedentary habits and diminished physical activity, contributing to issues like obesity, poor circulation, and other risk factors for CVDs. Point-of-care lipid tests facilitate the handling of the increasing prevalence of cardiovascular diseases by offering rapid, on-site measurements of cholesterol and other lipid levels, allowing for early detection of risk and swift treatment choices to hinder disease advancement. For example, in January 2024, the American Heart Association, a US-based nonprofit organization, reported that cardiovascular disease-related deaths in the cardiovascular sector reached 931,578, an increase of 3,000 fatalities from the prior year’s total of 928,741. Consequently, the growing prevalence of cardiovascular diseases is anticipated to drive the point of care lipid test market’s growth.

    Point Of Care Lipid Test Market Segmentation And Category Overview

    The point of care lipid test market covered in this report is segmented –

    1) By Product Types: Instruments, Consumables

    2) By Application: Hyperlipidemia, Hypertriglyceridemia, Hyperlipoproteinemia, Familial Hypercholesterolemia, Other Applications

    3) By End-User: Hospitals, Clinics, Home Care Settings, Other End Users

    Subsegments:

    1) By Instruments: Portable Or Handheld Analyzers, Multi-parameter Analyzers, Single-parameter Analyzers

    2) By Consumables: Test Strip, Reagents And Kits

    Point Of Care Lipid Test Market Strategic Trends: What Defines The Next Growth Phase?

    Key companies operating in the point-of-care lipid test market are concentrating on innovative solutions, such as advanced point-of-care (POC) diagnostic platforms, to provide rapid, accurate, and lab-quality lipid panel results directly at the patient’s bedside, thereby enhancing clinical decision-making and patient management. An advanced point-of-care (POC) diagnostic platform is defined as a portable, integrated device that executes quick, precise, and lab-quality tests close to the patient, facilitating real-time clinical decisions and immediate health management. For example, in July 2023, Vital Biosciences Inc., a health technology company based in Canada, launched VitalOne, a point-of-care lab testing platform engineered to deliver over 50 lab-grade blood test results in just 20 minutes utilizing a compact, automated device at locations such as clinics and pharmacies. This system unifies hematology, clinical chemistry, and immunoassays within a single instrument, allowing healthcare providers to complete testing, diagnosis, and treatment in one visit, significantly improving access, speed, and personalization of patient care, all with accuracy comparable to traditional central labs.

    Point Of Care Lipid Test Market Industry Leaders And Competitive Landscape

    Major companies operating in the point of care lipid test market are Abbott Laboratories, EKF Diagnostics Holdings plc, Roche Diagnostics International AG, Siemens Healthineers AG, Horiba ABX SAS, Randox Laboratories Ltd., Sekisui Diagnostics LLC, EKF Diagnostics USA Inc., VivaChek Biotech (Hangzhou) Co. Ltd., Menarini Diagnostics S.r.l., Trinity Biotech plc, AccuBioTech Co. Ltd., MiCo BioMed Co. Ltd., BHR Diagnostics Private Limited, SD Biosensor Inc., ARKRAY Inc., PTS Diagnostics, HemoCue AB, MedTest Dx Inc., Nova Biomedical Corporation

    View The Full Point Of Care Lipid Test Market Report:

    https://thebusinessresearchcompany.com/report/point-of-care-lipid-test-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Point Of Care Lipid Test Market Regional Analysis And Top Geography

    North America was the largest region in the point of care lipid test market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point of care lipid test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Reach Out To Our Team:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Point Of Care Hematology Diagnostics Market 2026 Outlook: Market Size, CAGR And Key Growth Opportunities

    Point Of Care Hematology Diagnostics Market 2026 Outlook: Market Size, CAGR And Key Growth Opportunities

    Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

    Point Of Care Hematology Diagnostics Market Set To Climb From $3.16 Billion In 2026 To $4.39 Billion By 2030

    The point of care hematology diagnostics market size has demonstrated significant expansion in recent years. This market is anticipated to increase from $2.9 billion in 2025 to $3.16 billion in 2026, registering a compound annual growth rate (CAGR) of 9.0%. Its historical growth was influenced by factors including reliance on centralized laboratory testing, the escalating prevalence of anemia and blood disorders, a rise in hospital emergency admissions, the demand for expedited diagnostic turnaround times, and restricted access to laboratory infrastructure in rural areas.

    The point of care hematology diagnostics market is projected to experience substantial expansion in the coming years. This market is set to reach a valuation of $4.39 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.6%. This anticipated growth during the forecast period is driven by several factors, including the increasing incidence of chronic and infectious diseases, the expansion of point of care testing initiatives, a heightened need for swift diagnostics in emergency situations, innovations in compact hematology analyzers, and the proliferation of decentralized healthcare delivery systems. Key trends expected over the forecast period encompass a greater uptake of rapid bedside blood testing, an increasing requirement for decentralized diagnostics in urgent care environments, the wider deployment of portable and handheld hematology instruments, the extension of point of care testing into regions with limited resources, and an emphasis on reducing turnaround times for quicker clinical decision-making.

    Get A Free Sample Report With In-Depth Market Insights:

    https://thebusinessresearchcompany.com/sample_request?id=94558990&type=smp&name=Point%20Of%20Care%20Hematology%20Diagnostics%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Point Of Care Hematology Diagnostics Market Development Factors: What’s Supporting Demand?

    The growing prevalence of blood disorders is expected to drive the expansion of the point-of-care hematology diagnostics market in the future. Blood disorders are defined as conditions that impact the blood’s components, such as red blood cells, white blood cells, platelets, or plasma. This increasing incidence of blood disorders is primarily linked to the rising occurrence of chronic diseases, which directly affect blood health and require continuous monitoring. Point-of-care hematology diagnostics assist in the early detection and management of blood disorders by offering rapid, accurate results directly at or near the patient’s location, enabling quicker clinical decisions and improved disease management. For instance, in November 2024, The American Society of Hematology, a US-based Non-profit organization, projected that global leukemia cases could reach approximately 519,540 by 2050. Therefore, the increasing incidence of blood disorders is a key factor boosting the growth of the point-of-care hematology diagnostics market.

    Point Of Care Hematology Diagnostics Market Segment Outlook: Which Categories Are Growing Fastest?

    The point of care hematology diagnostics market covered in this report is segmented –

    1) By Type: Complete Blood Count, Coagulation Testing, Hemoglobin Testing, Anemia Diagnosis, Other Types

    2) By Mode Of Prescription: Prescription Based Product, Over-The-Counter Based Product

    3) By End User: Diagnostic Centers, Hospitals, Blood Banks, Transfusion Centers, Other End Users

    Subsegments:

    1) By Complete Blood Count: White Blood Cell Count, Red Blood Cell Count, Platelet Count, Hematocrit, Hemoglobin Concentration, Mean Corpuscular Volume (MCV)

    2) By Coagulation Testing: Prothrombin Time (PT), Activated Partial Thromboplastin Time (aPTT), International Normalized Ratio (INR), D-Dimer Test, Fibrinogen Level

    3) By Hemoglobin Testing: Total Hemoglobin, Glycated Hemoglobin (HbA1c), Oxyhemoglobin, Carboxyhemoglobin, Methemoglobin

    4) By Anemia Diagnosis: Iron Studies, Vitamin B12 Levels, Folate Levels, Reticulocyte Count, Ferritin Test, Transferrin Saturation

    5) By Other Types: Blood Typing And Crossmatching, Erythrocyte Sedimentation Rate, Malaria Parasite Detection, Sickle Cell Screening, C-Reactive Protein Testing

    Point Of Care Hematology Diagnostics Market Transformation Trends: What Innovations Are Driving Change?

    Leading companies in the point-of-care hematology diagnostics market are prioritizing the creation of innovative solutions, such as cartridge-based AI-powered hematology analyzers, to provide swift, precise, and immediate blood testing for enhanced patient outcomes. These analyzers are characterized as compact diagnostic instruments that employ disposable reagent cartridges and artificial intelligence technology for the rapid and precise examination of blood specimens directly where care is given. An example of this is Zoetis Inc., a US-based veterinary health company, which in September 2024 introduced Vetscan OptiCell, a cartridge-based, AI-powered hematology analyzer tailored for animal health applications. This advanced device provides swift and high-standard complete blood count (CBC) outcomes on-site in a matter of minutes, simultaneously minimizing upkeep and operational effort. Featuring sophisticated AI-powered image processing and viscoelastic focusing capabilities, it accurately positions cells for optimal visualization, facilitating precise blood cell categorization and automatic detection of irregularities, consequently guaranteeing effective and dependable diagnostic results for animals.

    Point Of Care Hematology Diagnostics Market Key Participants And Competitive Landscape

    Major companies operating in the point of care hematology diagnostics market are F. Hoffmann‑La Roche Ltd., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Shenzhen Mindray Bio‑Medical Electronics Co. Ltd., Sysmex Corporation, HORIBA Ltd., Nova Biomedical Corp., S.D. Sight Diagnostics Ltd., EKF Diagnostics Holdings plc., BioMedomics Inc., PixCell Medical Technologies Ltd., Boule Diagnostics AB, Nihon Kohden Corporation, Edan Instruments Inc., A Menarini Industrie Farmaceutiche Srl, Becton Dickinson and Company, Ortho Clinical Diagnostics, Khema Diagnostics, Bio‑Rad Laboratories Inc.

    View The Full Point Of Care Hematology Diagnostics Market Report:

    https://thebusinessresearchcompany.com/report/point-of-care-hematology-diagnostics-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Point Of Care Hematology Diagnostics Market Geographic Analysis: Where Is Demand Rising Fastest?

    North America was the largest region in the point of care hematology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point of care hematology diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Reach Out To Our Team:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Point Of Care Devices Market Size Growth: From $34.44 Billion In 2026 To $48.88 Billion By 2030

    Point Of Care Devices Market Size Growth: From $34.44 Billion In 2026 To $48.88 Billion By 2030

    Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

    Point Of Care Devices Market Forecast: Value Set To Climb From $34.44 Billion To $48.88 Billion

    The point of care devices market size has experienced robust expansion in recent years. Projections indicate its valuation will ascend from $31.46 billion in 2025 to $34.44 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.5%. Historically, this market’s expansion was driven by factors such as restricted access to centralized laboratory services, the increasing prevalence of chronic ailments, the imperative for quicker clinical determinations, the proliferation of primary healthcare establishments, and a heightened demand for bedside diagnostic solutions.

    The point of care devices market is anticipated to show significant expansion over the next few years. It will grow to $48.88 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. This projected growth during the forecast period is largely due to advancements in microfluidics and biosensors, the rising acceptance of wearable and remote monitoring devices, an increase in home healthcare environments, growing requirements for infectious disease surveillance, and the integration of digital health platforms. Prominent trends for the forecast period encompass the increasing adoption of rapid diagnostic testing at care facilities, a greater demand for home-based and self-testing products, the miniaturization of diagnostic and monitoring tools, an escalating focus on decentralized healthcare provision, and the broadening of point of care testing within emergency and critical care settings.

    Get A Free Sample Report With In-Depth Market Insights:

    https://thebusinessresearchcompany.com/sample_request?id=79367464&type=smp&name=Point%20Of%20Care%20Devices%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Point Of Care Devices Market Industry Drivers: What’s Behind The Revenue Growth?

    The increasing need for diagnostic imaging is anticipated to propel the growth of the point-of-care devices market moving forward. Diagnostic imaging encompasses techniques and processes utilized to create visual representations of the body’s interior for clinical analysis and medical intervention. The demand for diagnostic imaging is escalating due to the rising occurrence of chronic conditions that require early and accurate diagnosis. Point-of-care devices augment diagnostic imaging by providing compact and mobile designs, making them perfectly suited for clinics, bedside use, and remote healthcare environments. They contribute to reduced turnaround time by delivering rapid and accurate imaging results, which in turn improves clinical decision-making and the efficiency of patient care. For instance, in November 2024, as per the National Health Service, a UK-based government agency, 47.2 million imaging tests were reported in England in the year to March 2024, showing an increase of 4.8% from 45.0 million recorded in the previous year. Therefore, the expanding demand for diagnostic imaging is a key driver for the growth of the point-of-care devices market.

    Point Of Care Devices Market Segment Landscape: Which Areas Lead Development?

    The point of care devices market covered in this report is segmented –

    1) By Type Of Device: Diagnostic Devices, Therapeutic Devices, Monitoring Devices, Treatment Devices, Support Devices

    2) By Technology: Biochemical Technology, Microfluidics, Immunoassay Technology, Nucleic Acid Testing, Wearable Technology

    3) By Application: Cardiology, Diabetes Management, Infectious Diseases, Oncology, Pediatrics

    4) By Distribution Channel: Direct Sales, Distributors, Online Sales, Retail Pharmacies, Healthcare Institutions

    5) By End User: Hospitals, Clinics, Home Care Settings, Diagnostic Laboratories, Emergency Medical Services (EMS)

    Subsegments:

    1) By Diagnostic Devices: Blood Glucose Monitors, Hematology Analyzers, Coagulation Analyzers, Urinalysis Devices, Molecular Diagnostics

    2) By Therapeutic Devices: Infusion Pumps, Respiratory Therapy Devices, Pain Management Devices, Wound Care Devices, Dialysis Devices

    3) By Monitoring Devices: Vital Signs Monitors, Cardiac Monitors, Pulse Oximeters, Temperature Monitors, Respiratory Monitors

    4) By Treatment Devices: Defibrillators, Surgical Devices, Laser Therapy Devices, Physical Therapy Devices

    5) By Support Devices: Sample Collection Devices, Specimen Transport Devices, Data Management Devices, Calibration And Maintenance Devices

    #Point Of Care Devices Market Growth Trends: What’s Shaping The Future Outlook?

    Leading companies in the point-of-care devices market are concentrating on developing technologically advanced solutions, including artificial intelligence-enhanced handheld ultrasound systems, to enhance diagnostic precision and portability. These artificial intelligence-enhanced handheld ultrasound systems are portable imaging tools that utilize AI algorithms to aid in capturing and interpreting ultrasound images for quicker and more accurate diagnoses. As an example, in October 2023, Koninklijke Philips N.V., a Netherlands-based healthcare technology company, launched the Compact 5000 Series, an AI-enhanced point-of-care ultrasound system. This portable device offers superior image quality combined with advanced AI-driven automation for measurements and streamlined workflows, facilitating rapid and accurate diagnostics across various healthcare settings. It also boasts user-friendly controls, supports multiple transducers, and integrates seamlessly with telemedicine platforms to enable collaborative remote clinical care.

    Point Of Care Devices Market Top Companies Driving Competitive Growth

    Major companies operating in the point of care devices market are Johnson & Johnson, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Hologic Inc., BioMérieux SA, Quidel Corporation, OraSure Technologies Inc., Nova Biomedical Corporation, Sekisui Diagnostics LLC, Abaxis Inc., EKF Diagnostics Holdings plc, Trinity Biotech plc, Chembio Diagnostics Inc., PTS Diagnostics LLC, MeMed, Alere Inc., Diagnostics For All Inc.

    View The Full Point Of Care Devices Market Report:

    https://thebusinessresearchcompany.com/report/point-of-care-devices-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Point Of Care Devices Market Global Footprint: Which Region Leads The Market?

    North America was the largest region in the point of care devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point of care devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Reach Out To Our Team:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model